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Abstract: The study basing on examination of 102 children with bronchial asthma defines indices of inflammatory activity in the 
airways and sets the diagnostic value of these indices as tests for verification exercise-induced bronchial asthma. The children with no 
signs of exercise-induced asthma compared to patients having them, were shown to experience some changes in the exhaled breath 
condensate, indicating a higher activity of inflammation in the airways. The content of nitrogen monoxide metabolites less than 50 
mcmol/L or markers of proteolytic activity by azocol lysis less than 0.2 ml/hour in pulmonary expiration products increase the chances 
of having exercise-induced bronchial asthma phenotype with these tests sensitivity within 66.7-75.7%. 
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———————————————————— 
INTRODUCTION       
According to the definition of PRACTALL [1], exercise-
induced bronchial asthma (EIBA) is regarded as a type of 
asthma associated with exercise-induced transient bron-
chial obstruction [2, 3]. At the same time exercise-induced 
bronchospasm (EIBS) is objectively defined as reduction of 
FEV1 by 10% and more compared to the initial value after a 
bronchoprovocation test [4, 5]. The detection rate of EIBA 
and EIBS in pediatric populations varies in quite a wide 
range depending on the terminology, which the researchers 
prefer, choosing populations, using different objective 
criteria of the disease with an arbitrary choice of the dis-
tribution point of the results, taking into account factors 
that affect the severity of EIBA. The causal role of inflam-
mation in exercise-induced bronchial obstruction in pa-
tients with bronchial asthma (BA) and people without the 
disease has been confirmed by many studies [6].  
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For instance, based on the examination of patients with 
asthma and otherwise healthy children, we noted that in 
EIBA the rate of leukotrienes in exhaled breath condensate 
increased by half and reliably correlated with decreased 
FEV1 after exercise. It enabled to assume that 
leukotrienes, along with nitrogen monoxide, are actively 
involved in the development of exercise-induced 
bronchoconstriction [7]. Howerer, it should be noted that 
the role of nitrogen monoxide in the formation of EIBA is 
ambiguous. For instance, it was noted that its content in 
the exhaled breath condensate does not correlate with 
spirographic changes [8], but, in the event of EIBA, its 
content in exhaled air may increase, decrease or not 
change significantly [9, 10]. Still, the low level of NO in 
exhaled air can probably be seen as a marker of the 
absence of EIBA in screening studies in cohorts of young 
children suffering from asthma [11]. Thus, the available 
information concerning airway inflammation markers found 
in exhaled breath condensate, can now be considered 
contradictory and unclear. 
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2.1 Purpose  
The aim of the study is to identify the signs of 
inflammatory activity in the airways of children with 
exercise-induced asthma.  
2.2 Subjects & Methods 
For this purpose we examined 102 schoolchildren with 
asthma at Pulmonary and Allergy department of Chernivtsi 
Regional Pediatric Hospital. In the article we used the 
classification and management of asthma according to 
"Unified clinical protocols of primary, secondary 
(specialized) medical care" Asthma in Children "(MOH of 
Ukraine number 868 of October 8, 2013) with the 
guidelines of The International global initiative for the 
diagnosis and treatment of asthma (GINA 2006-2010) [12-
14], NAEPP-2008 [15], ICON-2012 [16], approvals 
PRACTALL-2008 [17] and national protocols of Australia 
(2008) [18], UK (2011) [19], Japan (2010) [20]. The 
diagnosis of exercise-induced asthma (EIBA) was 
formulated according to the recommendations of 
PRACTALL-2008 [17], the European Respiratory Society 
(ERS) and the European Academy of Allergology and 
Clinical Immunology (EAACI) in cooperation with GALEN 
(2008) [21].  
The survey was conducted in parallel groups formed on 
the basis of a simple random selection using the 
"experiment-control" method. Based on the examination of 
the children, we formed two clinical groups. The first 
(Group I, basic) group included 50 schoolchildren 
diagnosed with EIBA, and the comparison group (Group II) 
consisted of 52 patients suffering from BA without signs of 
exercise-induced bronchospasm (EIBS). The average age of 
children in the first clinical group was 11.2±0.4 (95% CI 
10.3-12.1) year. The first group involved 22 girls (44.0%) 
and 28 (56.0%) boys. Furthermore, 27 children (54.0%) 
were rural inhabitants and 23 patients (46.0%) were city 
dwellers. The average disease duration was 6.18±0.45 (95% 
CI 5.3-7.1) years. The second clinical group comprised 16 
girls (30.8%) and 36 (69.3%) boys. The average age of 
patients in the second clinical group was 12.02±0.46 (95% 
CI 11.1-12.9) years and 25 children (48.1%) lived in the 
rural area while 27 patients (51.9%) were city dwellers. 
The average duration of disease reached 6.77±0.55 (95% CI 
5.7-7.9) years. These data give reason to believe that 
comparison groups did not differ significantly in the main 
clinical characteristics, and therefore were comparable.  
We identified inflammation signs in the exhaled breath 
condensate (EBC) of all the children: total protein by the 
method of Lowry O.H.[22]; concentration of nitrogen 
monoxide metabolites by N.L. Yemchenko [23]; markers of 
proteolytic activity by azoalbumin, azocasein and 
azocollagen lysis by K.N. Veremeyenko et al. [24]; the 
content of aldehid- and keto- secondary products of 2,4-
dinitrophenylhydrazines (AKDNFH) of basic and neutral 
nature by O.E. Dubinina et al. [25]; catalase activity by 
M.A. Koroliuk et al. [26].  
To determine the diagnostic value of the findings 
obtained in the comprehensive survey of children as the 
verification tests of EIBA, we determined their sensitivity 
as a test, specificity, predictive value of positive and 
negative results by defining confidence intervals (95% CI). 
Based on these characteristics of the test, we determined 
the ratio of reliability of positive and negative results, as 
well as post-test probability of the event with positive and 
negative test results. Risk assessment of the 
implementation of events was carried out on the basis of 
probability of relative, attributive risks and odds ratios 
events while defining their confidence intervals (95% CI).  
Conflict of interests 
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3 RESULTS AND DISCUSSION 
It should be noted that the content of nitrogen monox-
ide metabolites (NMM) in exhaled breath condensate, 
which can be seen as an integral indicator of inflammatory 
activity, was reduced in children of the first clinical group 
compared to the comparison group of patients. For in-
stance, the average content of NMM metabolites in pa-
tients with EIBA was 47.27±3.1 (95% CI 49.96-37.54) 
mmol/L. The representatives of the second clinical group 
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had the content of NMM metabolites in EBC as high as 
48.78±3.67 (95% CI 56.27-41.29) mmol/L (P>0.05). Despite 
the absence of reliable inter-group differences, the fre-
quency of found NMM metabolites in EBC content more 
than 50,0 mmol/L in the first group was 24.3% of cases and 
39.4% of cases in the comparison group (P>0.05). Perhaps 
the lack of probable differences on this inflammatory 
marker is due to the fact that it reflects both the activity 
of the inflammatory process and its protective role in rela-
tion to the inflammation process.  
According to the literature, inflammation markers in 
the bronchi, which are found in EBC were supposed to be 
more pronounced in children of the second clinical group. 
Indeed, the content of products of protein peroxidation in 
EBC, which can be considered as an indicator of activity of 
oxidative stress in the bronchi, in these children was 
slightly higher than in patients with EIBA (Table. 1). How-
ever, a slight increase of total protein in EBC is likely to be 
regarded as an indicator of more pronounced vascular 
permeability that accompanies inflammation and can be 
seen as a manifestation of "leakage" syndrome. 
Table 1. 
Indices of lipid peroxidation in EBC in children of the 
comparison clinical groups (M±m) 
 
Clinical 
groups 
Number 
of 
children 
Total 
protein, 
g/l 
AKDNFH of 
basic nature, 
o.u.g of pro-
tein 
AKDNFH of 
neutral 
nature, 
o.u.g of 
protein 
Group І  30 3,76±0,23 48,51±6,69 9,4±2,4
9 
Group ІІ 41 4,22±0,27 50,8±5,62 5,89±0,
63 
Р >0,05 >0,05 >0,05 
Note: Р – Student’s test; AKDNFH – aldehid- and keto- secondary 
products of 2,4-dinitrophenylhydrazines 
 
 
Proteolytic activity of EBC, expressed in ml/h, which 
can be regarded as an additional criterion for assessing the 
activity of inflammation in the bronchi, did not differ sig-
nificantly in the comparison groups and tended to prevail 
in the second clinical group (Fig. 1).  
 
 
 
Note: in all cases P>0.05 
Fig. 1. Results of expired breath condensate proteolytic 
activity (ml/h on azoalbumin, azocasein and azocol 
lysis in the children under study 
 
Lower activity of catalase in EBC that serves as a key 
enzyme of antioxidant bronchial defense must have con-
tributed to the development of more active inflammation 
in the airways of children from the second clinical group. 
For instance, in children with no signs of EIBA the catalase 
activity in EBC amounted to 46.93±5.6 (95% CI 34.0-79.8) 
mmol/min x mg of protein, and 58.19±3.1 (95% CI 33.1-
83.3) mmol/min x mg of protein in children of the first 
clinical group. The activity of catalase less than 40.0 
mmol/min x mg of protein in patients with EIBA was found 
in 61.9% of cases and in those from the comparison group 
in 73.7% of cases. 
According to current ideas, chronic inflammation of the 
airways, which in patients with clinically significant EIBS 
has more pronounced transitory nature is a basis of asthma 
pathogenesis and its particular phenotype EIBA [27]. There-
fore, it was appropriate to study the diagnostic value of 
some signs of bronchial inflammation in EBC, in particular, 
the level of nitrogen monoxide metabolites (NMM), total 
protein and products of oxidative modification (basic and 
neutral AKDNFH). The results of this analysis are presented 
in Table 2. It should be noted that more sensitive tests (the 
content of nitrogen monoxide metabolites in EBC <50.0 
mmol/L and total protein <4.0 g / L) increased the likeli-
hood of post-test EIBA with positive result not more than 
by 5.0%.  
 
 
INTER COLLEGAS, VOL. 4, No. 1 (2017)                                               ~ 17 ~ 
ISSN 2409-9988 
 
  
 
 
Table 2. 
Diagnostic value of some 
indices of the expired breath condensate for EIBA verification 
Indices of EBC 
Diagnostic value, % (95% CI) Likelihood ratio  
Sensitivity  Singularity 
Prognostic value 
Positive  
result 
Negative 
 result 
positive result negative result   
Total protein  < 4.0 g/l 63.3 
(53-72) 
48.8 
(39-59) 
55.3 
(46-65) 
57.1 
(46-68) 
1.24 0.75 
Basic AKDNFH >55.0 o.u.g of 
protein 
40.0 
(30-50) 
74.3 
(65-83) 
60.9 
(48-73) 
55.3 
(46-64) 
1.56 0.81 
Neutral AKDNFH >10.0 o.u.g of 
protein 
20.0 
(13-29) 
86.0 
(78-92) 
58.8 
(41-75) 
51.8 
(44-60) 
1.43 0.93 
Nitrogen monoxide metabolites 
<50.0 mcmol/L 
75.7 
(66-84) 
39.3 
(30-50) 
55.4 
(47-64) 
61.9 
(49-74) 
1.25 
 
0.62 
Azoalbumine lysis <1.2 ml/h 16.7 
(10-25) 
87.5 
(79-93) 
57.2 
(38-75) 
51.2 
(43-59) 
1.34 0.95 
Azocasein lysis >1.5 ml/h 50.0 
(40-60) 
56.3 
(44-66) 
53.4 
(43-64) 
53.0 
(43-63) 
1.14 0.89 
Azocol lysis <0.2 ml/h 66.7 
(56-76) 
50.0 
(40-60) 
57.2 
(48-66) 
60.0 
(49-70) 
1.33 0.67 
 
At the same time, the content of basic and neutral 
AKDNFH in EBC increased the post-test likelihood of this 
phenotype in case of a positive result by 11.0% and 8.0%, 
respectively.  
However, all of the suggested indices, meant, to some 
extent, a probable risk of realization of this phenotype of 
asthma in the examined patients (Table 3).  
 
  
Table 3. 
Clinical and epidemiological risk of EIBA 
depending on some indices of exhaled breath condensate 
Indices of EBC Odds ratio (95% CІ) Relative risk (95% CІ) Attributive risk 
Total protein  < 4.0 g/L 1.64 (0.9-2.9) 1.29 (1.0-1.6) 0.12 
Basic AKDNFH >55.0 o.u.g of protein 1.93 (1.1-3.5) 1.36 (0.9-2.1) 0.16 
Neutral AKDNFH >10.0 o.u.g of protein 1.54 (0.7-3.2) 1.22 (0.6-2.3) 0.11 
Nitrogen monoxide metabolites <50.0 mcmol/L 2.02 (1.1-3.7) 1.45 (1.2-1.8) 0.17 
Azoalbumin lysis <1.2 ml/h 1.4 (0.6-3.1) 1.17 (0.6-2.3) 0.08 
Azocasein lysis >1.5 ml/h 1.29 (0.7-2.2) 1.13 (0.8-1.5) 0.06 
Azocol lysis <0.2 ml/h 2.0 (1.13-3.6) 1.43 (1.1-1.8) 0.17 
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These findings give reason to believe that the probable 
risk of EIBA is indicated by higher sensitivity tests. Howev-
er, it should be noted that, from a clinical point of view, 
the above mentioned risks of EIBA should be seen as rather 
modest arguments in favor of this phenotype of the dis-
ease. 
 
4  CONCLUSIONS 
Thus, the children with no signs of exercise-induced 
asthma compared to patients having them, experience 
some changes in the exhaled breath condensate, indicating 
a higher activity of inflammation in the airways. The con-
tent of nitrogen monoxide metabolites <50 mcmol/L or 
markers of proteolytic activity by azocol lysis <0.2 ml/h in 
pulmonary expiration products increase the chances of 
having EIBA phenotype with these tests sensitivity within 
66.7-75.7%. 
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